Icahn's Icahn Capital Boosts Stake in Biogen (BIIB) to Nearly 10M Shares

Carl Icahn's Icahn Capital latest 13F shows he raised his stake in Biogen Idec (Nasdaq: BIIB).

Icahn's filing showed he boosted his stake from 8,256,723 shares to 9,948,723 shares.

Biogen Idec, Inc. engages in the development, manufacture, and commercialization of novel therapies primarily in the areas of oncology, neurology, immunology, and cardiology in the United States and internationally.

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• On Holding AG (ONON) Insider Trades
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation